login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
INTERSECT ENT INC (XENT) Stock News
NASDAQ:XENT - Nasdaq -
US46071F1030
-
Common Stock
28.24
0 (0%)
After market: 28.24
0 (0%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
XENT Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Intersect ENT, Inc.
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization
4 years ago - By: Zacks Investment Research
Why Is Intersect ENT (XENT) Down 0.6% Since Last Earnings Report?
4 years ago - By: Zacks Investment Research
- Mentions:
MDT
CHE
MEDP
Intersect ENT's (XENT) Sell-Off on Track Amid COVID Woes
4 years ago - By: Zacks Investment Research
Intersect ENT (XENT) Reports Q3 Loss, Lags Revenue Estimates
4 years ago - By: Intersect ENT, Inc.
Intersect ENT Reports Third Quarter 2021 Financial Results
4 years ago - By: Intersect ENT®, Inc.
First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe
4 years ago - By: Zacks Investment Research
Analysts Estimate Intersect ENT (XENT) to Report a Decline in Earnings: What to Look Out for
4 years ago - By: Monteverde & Associates PC
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Intersect ENT, Inc. - XENT
4 years ago - By: Halper Sadeh LLP
- Mentions:
INOV
LMRK
JAX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm
4 years ago - By: Halper Sadeh LLP
- Mentions:
GTS
INOV
XONE
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, GTS, XONE, XENT; Shareholders are Encouraged to Contact the Firm
4 years ago - By: Halper Sadeh LLP
- Mentions:
CSOD
FFWM
RIVE
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, XENT, FFWM, RIVE; Shareholders are Encouraged to Contact the Firm
Please enable JavaScript to continue using this application.